Detecting oral kallikrein-targeting therapy through triggered contact activation: A phase I study

Zonne L M Hofman; Chantal C Clark; C Erik Hack; Steven de Maat; Coen Maas

doi:10.1016/j.jaci.2020.03.038

Detecting oral kallikrein-targeting therapy through triggered contact activation: A phase I study

Zonne L M Hofman, Chantal C Clark, C Erik Hack, Steven de Maat, Coen Maas

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	1446-1449.e5
Journal	The Journal of Allergy and Clinical Immunology
Volume	146
Issue number	6
Early online date	29 Apr 2020
DOIs	https://doi.org/10.1016/j.jaci.2020.03.038
Publication status	Published - Dec 2020

Access to Document

10.1016/j.jaci.2020.03.038

Cite this

@article{5b792e16b7a0496382a1670b77690e98,

title = "Detecting oral kallikrein-targeting therapy through triggered contact activation: A phase I study",

author = "Hofman, {Zonne L M} and Clark, {Chantal C} and Hack, {C Erik} and {de Maat}, Steven and Coen Maas",

note = "Funding Information: Sponsored by Attune Pharmaceuticals. Z.L.M. Hofman received an Alexandre Suermann grant from the Utrecht University Medical Center . Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2020",

month = dec,

doi = "10.1016/j.jaci.2020.03.038",

language = "English",

volume = "146",

pages = "1446--1449.e5",

journal = "The Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Mosby Inc.",

number = "6",

}

TY - JOUR

T1 - Detecting oral kallikrein-targeting therapy through triggered contact activation

T2 - A phase I study

AU - Hofman, Zonne L M

AU - Clark, Chantal C

AU - Hack, C Erik

AU - de Maat, Steven

AU - Maas, Coen

N1 - Funding Information: Sponsored by Attune Pharmaceuticals. Z.L.M. Hofman received an Alexandre Suermann grant from the Utrecht University Medical Center . Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2020/12

Y1 - 2020/12

UR - http://www.scopus.com/inward/record.url?scp=85085523032&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2020.03.038

DO - 10.1016/j.jaci.2020.03.038

M3 - Letter

C2 - 32360287

SN - 0091-6749

VL - 146

SP - 1446-1449.e5

JO - The Journal of Allergy and Clinical Immunology

JF - The Journal of Allergy and Clinical Immunology

IS - 6

ER -

Detecting oral kallikrein-targeting therapy through triggered contact activation: A phase I study

Access to Document

Other files and links

Cite this